IPP Bureau
ACG to set up Asia's largest capsule plant in Maharashtra
By IPP Bureau - November 24, 2021
Officials from ACG signed the MoU with the Maharashtra government for the Rs 600 crore investment in the backward region of Marathwada
Arrowhead Pharmaceuticals enters agreement with GSK to develop NASH drug candidate
By IPP Bureau - November 24, 2021
Arrowhead to receive US $ 120 million upfront payment for Phase 1/2 program for NASH and is eligible to receive potential milestone payments and royalties on commercial sales
U.S. FDA approves first treatment for drug-resistant post-transplant infection
By IPP Bureau - November 24, 2021
The approval is for Cytomegalovirus, a type of Herpes virus
Vivera announces launch of new testing software, LabPort
By IPP Bureau - November 24, 2021
Featuring identity verification using artificial intelligence (AI), LabPort was designed to facilitate immediate results reporting for diagnostic testing even in high-volume, field-based testing environments
Serum Life Sciences invests US $ 10 million in GreenLight Biosciences
By IPP Bureau - November 24, 2021
GreenLight Biosciences is a Boston-based biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible
Ipca Laboratories acquires 26 % stake in Lyka Labs, makes open offer
By IPP Bureau - November 24, 2021
For the six months ended September 30, 2021, Lyka had reported revenues of Rs 109.87 crore
Fortis Escorts Faridabad introduces Cryo technique to treat lung cancer
By IPP Bureau - November 24, 2021
Cryo-technology helps in early diagnosis and palliative care in later stages of cancer
Vital Strategies India appoints L. M. Singh as MD, India and Global Head, Partnerships and Innovative Finance
By IPP Bureau - November 24, 2021
In his new role as Managing Director India and Global Head, Partnerships and Innovative Finance, Singh will oversee the financial, human, and operational functions of the India office
Asian Development Bank to loan US $ 300 mn to improve India’s primary healthcare
By IPP Bureau - November 24, 2021
The programme will be implemented across 13 states and benefit 256 min
Indian pharma CEOs bet big on innovation to achieve US $130 bn
By IPP Bureau - November 23, 2021
While industry steps out of its comfort zone to innovate, the government has to support by allocating funds across research lifecycle and offer incentives for innovation
AstraZeneca opens Discovery Centre in Cambridge
By IPP Bureau - November 23, 2021
State-of-the-art R&D facility designed to foster collaboration across world-class science ecosystem
Obseva announces U.S. FDA acceptance of new drug application for linzagolix
By IPP Bureau - November 23, 2021
Obseva announced previously that the company has entered into a partnership with Syneos Health to support commercialization of linzagolix in the US and EU
Boehringer Ingelheim gets CDSCO nod for Jardiance
By IPP Bureau - November 23, 2021
Jardiance is the first SGLT2-inhibitor therapy to prove reduction in risk of cardiovascular death in people with type-II diabetes and established cardiovascular disease
U.S. FDA approves Alembic’s Formoterol Fumarate inhalation solution
By IPP Bureau - November 23, 2021
The ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies
Zydus Cadila submits NDA to Drug Controller General of India for Chronic Kidney Disease
By IPP Bureau - November 23, 2021
The NDA for Desidustat is based on positive data from the DREAM-ND and DREAM-D Phase 3 trials in patients with Chronic Kidney Disease (CKD) Not on Dialysis and Dialysis
